DiGeorge Syndrome

2

Review clinical trials related to DiGeorge Syndrome. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)

This is a research protocol that will examine Hematopoietic Stem Cell Transplantation (HSCT) using a reduced conditioning regimen (RIC) with total body Irradiation (TBI) in those diagnosed with Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD).

Participants needed: 25
Trial details
Phase: Phase 2Age: 5-40Biological sex: AllType: InterventionalSponsor: Paul SzabolcsUpdated: May 15, 2026Locations: 1
Eligibility criteria

Patient, parent, or legal guardian must have given written informed consent. For... [+29]

Allergy to Dimethylsulfoxide (DMSO) or any other ingredient used in the manufact... [+3]

Status: Recruiting

Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome

22q11.2 deletion syndrome is a genetic disorder that can cause heart defects, facial abnormalities, and developmental and learning disabilities. The severity of the disorder can vary widely among people. This study will analyze DNA from people with 22q11.2 deletion syndrome to identify genetic variations that may affect the severity of the disorder.

Participants needed: 1,000
Trial details
Biological sex: AllType: ObservationalSponsor: Albert Einstein College of MedicineUpdated: Jul 22, 2025Locations: 1
Eligibility criteria

Has 22q11 deletion of 3 megabases (Mb)

Has 22q11 deletion smaller than 3 Mb or no deletion